CLINICAL_TRIALS
research
· 2026-03-11
Clinical Trial Update: VITUS Post-Market Registry
Summary
A post-market registry for the VITUS device by OrbusNeich is currently recruiting to evaluate its performance in patients with peripheral arterial disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: OrbusNeich | Conditions: Peripheral Arterial Disease, Peripheral Arterial Occlusive Disease | Status: RECRUITING